Nonapnea sleep disorders and the risk of acute kidney injury: A nationwide population-based study

Medicine (United States)

Volumn 95, Issue 11, 2016, Pages

  Lin, Hugo You Hsien ^a,b,c   Chang, Kai Ting ^b   Chang, Yu Han ^a,b   Lu, Tzongshi ^d   Liang, Chan Jung ^a,b   Wang, Dean Chuan ^b   Tsai, Jui Hsiu ^b   Hsu, Chung Yao ^e   Hung, Chi Chih ^a   Kuo, Mei Chuan ^a   Lin, Chang Shen ^c   Hwang, Shang Jyh ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GOUT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCOME; INSOMNIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; NONAPNEA SLEEP DISORDER; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SLEEP DISORDER; URBANIZATION; ACUTE KIDNEY INJURY; AGE; COMORBIDITY; COMPLICATION; INCIDENCE; MIDDLE AGED; SEX DIFFERENCE; SLEEP WAKE DISORDERS; TAIWAN;

ACUTE KIDNEY INJURY; ADULT; AGE FACTORS; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEX FACTORS; SLEEP WAKE DISORDERS; TAIWAN;

EID: 84962027400     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003067     Document Type: Article

References (34)

1. Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18:1292-1298.
2. Liangos O, Wald R, O'Bell JW, et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1:43-51.
3. Wu VC, Wu CH, Huang TM, et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol. 2014;25:595-605.
4. Xue JL, Daniels F, Star RA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135-1142.
5. Wonnacott A, Meran S, Amphlett B, et al. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clin J Am Soc Nephrol. 2014;9:1007-1014.
6. Buysse DJ. Insomnia. JAMA. 2013;309:706-716.
7. Plantinga L, Lee K, Inker LA, et al. Association of sleep-related problems with CKD in the United States, 2005-2008. Am J Kidney Dis. 2011;58:554-564.
8. Sakaguchi Y, Shoji T, Kawabata H, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol. 2011;6:995-1000.
9. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-1384.
10. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053.
11. TM Cheng. Taiwan's national health insurance system: high value for the dollar. In: Okma K. G., Crivelli L., editors. Six Countries, Six Reform Models-The Healthcare Reform Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. Hackensack, NJ, USA: World Scientific; 2009. pp. 171-204.
12. Neubauer DN. New and emerging pharmacotherapeutic approaches for insomnia. Int Rev Psychiatry. 2014;26:214-224.
13. Lai TS, Wang CY, Pan SC, et al. Risk of developing severe sepsis after acute kidney injury: a population-based cohort study. Crit Care. 2013;17:R231.
14. Hsu TW, Liu JS, Hung SC, et al. Renoprotective effect of rennin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia. JAMA Int Med. 2014;174:347-354.
15. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
16. Benz RL, Pressman MR, Hovick ET, et al. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis. 2000;35:1052-1060.
17. Hanly P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial. 2004;17:109-114.
18. Agarwal R, Light RP. Sleep and activity in chronic kidney disease: a longitudinal study. Clin J Am Soc Nephrol. 2011;6:1258-1265.
19. Tochikubo O, Ikeda A, Miyajima E, et al. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension. 1996;27:1318-1324.
20. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43:678-683.
21. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-1439.
22. Knutson KL, Van Cauter E, Rathouz PJ, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Int Med. 2009;169:1055-1061.
23. Huang ST, Lin CL, Yu TM, et al. Nonapnea sleep disorders and incident chronic kidney disease: a population-based retrospective cohort study. Medicine. 2015;94:e429.
24. Lin HY, Hung CC, Chang YH, et al. Nonapnea sleep disorders in patients younger than 65 years are significantly associated with CKD: a nationwide population-based study. PloS One. 2015;10:e0140401.
25. Guo X, Yu S, Li Z, et al. Self-reported sleep duration is associated with reduced glomerular filtration rate among adults with hypertension: a population-based study from rural northeast China. J Sleep Res. 2015;24:351-358.
26. Sasaki S, Yoshioka E, Saijo Y, et al. Short sleep duration increases the risk of chronic kidney disease in shift workers. J Occup Env Med. 2014;56:1243-1248.
27. Turek NF, Ricardo AC, Lash JP. Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. Am J Kidney Dis. 2012;60:823-833.
28. Neumann J, Ligtenberg G, Klein II, et al. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int. 2004;65:1568-1576.
29. Brandenberger G, Follenius M, Goichot B, et al. Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. J Hypertens. 1994;12:277-283.
30. Charloux A, Gronfier C, Lonsdorfer-Wolf E, et al. Aldosterone release during the sleep-wake cycle in humans. Am J Physiol. 1999;276 (1 Pt 1):E43-E49.
31. Murck H, Uhr M, Ziegenbein M, et al. Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedi-cated patients with depression after total sleep deprivation. Pharma-copsychiatry. 2006;39:23-29.
32. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004;89:2119-2126.
33. Ohkuma T, Fujii H, Iwase M, et al. Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry. PloS One. 2013;8:e78968.
34. Sauvet F, Leftheriotis G, Gomez-Merino D, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol. 2010;108:68-75.